Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/117375
Title: Image-guided Embolotherapy of Arteriovenous malformations of the face
Author(s): Schmidt, Vanessa FranziskaLook up in the Integrated Authority File of the German National Library
Masthoff, MaxLook up in the Integrated Authority File of the German National Library
Brill, RichardLook up in the Integrated Authority File of the German National Library
Sporns, Peter B.Look up in the Integrated Authority File of the German National Library
Köhler, Michael
Schulze-Zachau, VictorLook up in the Integrated Authority File of the German National Library
Takes, Martin
Ehrl, DenisLook up in the Integrated Authority File of the German National Library
Puhr-Westerheide, DanielLook up in the Integrated Authority File of the German National Library
Kunz, Wolfgang GerhardLook up in the Integrated Authority File of the German National Library
Shemwetta, Mwivano Dunstan
Mbuguje, Eric M.
Naif, Azza A.
Sarkar, Abizer Sarkar
Ricke, JensLook up in the Integrated Authority File of the German National Library
Seidensticker, MaxLook up in the Integrated Authority File of the German National Library
Wohlgemuth, Walter A.Look up in the Integrated Authority File of the German National Library
Wildgruber, MoritzLook up in the Integrated Authority File of the German National Library
Issue Date: 2022
Type: Article
Language: English
Abstract: Purpose: To evaluate the safety and outcome of image-guided embolotherapy of extracranial arteriovenous malformations (AVMs) primarily affecting the face. Materials and Methods: A multicenter cohort of 28 patients presenting with AVMs primarily affecting the face was retrospectively investigated. Fifty image-guided embolotherapies were performed, mostly using ethylene–vinyl alcohol copolymer-based embolic agents. Clinical and imaging findings were assessed to evaluate response during follow-up (symptom-free, partial relief of symptoms, no improvement, and progression despite embolization), lesion devascularization (total, 100%; substantial, 76–99%; partial, 51–75%; failure, < 50%; and progression), and complication rates (classified according to the CIRSE guidelines). Sub-analyses regarding clinical outcome (n = 24) were performed comparing patients with (n = 12) or without (n = 12) subsequent surgical resection after embolotherapy. Results: The median number of embolotherapy sessions was 2.0 (range, 1–4). Clinical outcome after a mean follow-up of 12.4 months (± 13.3; n = 24) revealed a therapy response in 21/24 patients (87.5%). Imaging showed total devascularization in 14/24 patients (58.3%), including the 12 patients with subsequent surgery and 2 additional patients with embolotherapy only. Substantial devascularization (76–99%) was assessed in 7/24 patients (29.2%), and partial devascularization (51–75%) in 3/24 patients (12.5%). Complications occurred during/after 12/50 procedures (24.0%), including 18.0% major complications. Patients with subsequent surgical resections were more often symptom-free at the last follow-up compared to the group having undergone embolotherapy only (p = 0.006). Conclusion: Image-guided embolotherapy is safe and effective for treating extracranial AVMs of the face. Subsequent surgical resections after embolization may substantially improve patients’ clinical outcome, emphasizing the need for multimodal therapeutic concepts.
URI: https://opendata.uni-halle.de//handle/1981185920/119334
http://dx.doi.org/10.25673/117375
Open Access: Open access publication
License: (CC BY 4.0) Creative Commons Attribution 4.0(CC BY 4.0) Creative Commons Attribution 4.0
Journal Title: CardioVascular and interventional radiology
Publisher: Springer
Publisher Place: Berlin
Volume: 45
Original Publication: 10.1007/s00270-022-03169-0
Page Start: 992
Page End: 1000
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s00270-022-03169-0.pdf491.65 kBAdobe PDFThumbnail
View/Open